Ontario Teachers Pension Plan Board Sells 12,746 Shares of Colgate-Palmolive Company $CL

Ontario Teachers Pension Plan Board trimmed its stake in Colgate-Palmolive Company (NYSE:CLFree Report) by 25.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,502 shares of the company’s stock after selling 12,746 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Colgate-Palmolive were worth $2,998,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Tiemann Investment Advisors LLC raised its position in shares of Colgate-Palmolive by 2.1% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after acquiring an additional 125 shares in the last quarter. Westside Investment Management Inc. grew its stake in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the period. S.A. Mason LLC raised its holdings in Colgate-Palmolive by 3.9% in the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after purchasing an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA lifted its position in Colgate-Palmolive by 0.8% during the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after buying an additional 130 shares during the period. Finally, Stratos Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after buying an additional 130 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 184,683 shares of company stock worth $17,486,693 in the last three months. 0.34% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research report on Sunday, February 1st. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Piper Sandler boosted their price target on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $94.00 target price on shares of Colgate-Palmolive in a report on Saturday, January 31st. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $94.38.

Read Our Latest Report on CL

Colgate-Palmolive Stock Down 0.1%

Colgate-Palmolive stock opened at $95.52 on Thursday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The stock has a fifty day simple moving average of $84.94 and a two-hundred day simple moving average of $82.11. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The firm has a market cap of $77.00 billion, a price-to-earnings ratio of 36.46, a PEG ratio of 4.31 and a beta of 0.29.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period last year, the company earned $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 79.39%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.